CI
EW icon

Cowen Inc’s Edwards Lifesciences EW Stock Holding History

Cowen Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,018
Closed -$214K – 314
2015
Q2 		$214K Hold
9,018
– – 0.01% 350
2015
Q1 		$214K Buy
+9,018
New +$202K 0.02% 315

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Cowen Inc's EW Position: Q3 2015 in Review

Cowen Inc sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 9,018 shares — an estimated $214K sold.

Cowen Inc first reported a position in EW in Q1 2015 and held it in 2 quarters. The position peaked at $214K in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • Cowen Inc reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
  • Cowen Inc sold 9,018 Edwards Lifesciences shares in Q3 2015, an estimated $214K.
  • Cowen Inc first reported a position in Edwards Lifesciences in Q1 2015 and held it in 2 quarters.
  • Cowen Inc's Edwards Lifesciences position peaked at $214K in Q2 2015.
  • 569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.